107.72 USD
+0.34
0.32%
Updated Aug 26, 2:01 PM EDT
1 day
0.32%
5 days
1.02%
1 month
6.78%
3 months
4.17%
6 months
1.81%
Year to date
5.24%
1 year
0.20%
5 years
195.53%
10 years
278.50%
 

About: Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Employees: 12,694

0
Funds holding %
of 7,431 funds
0
Analysts bullish %
of 8 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

92% more call options, than puts

Call options by funds: $282M | Put options by funds: $147M

7% more first-time investments, than exits

New positions opened: 125 | Existing positions closed: 117

0.23% more ownership

Funds ownership: 66.87% [Q1] → 67.1% (+0.23%) [Q2]

2% less funds holding

Funds holding: 1,604 [Q1] → 1,572 (-32) [Q2]

6% less capital invested

Capital invested by funds: $40.6B [Q1] → $38.3B (-$2.31B) [Q2]

23% less repeat investments, than reductions

Existing positions increased: 492 | Existing positions reduced: 640

30% less funds holding in top 10

Funds holding in top 10: 27 [Q1] → 19 (-8) [Q2]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$98
9%
downside
Avg. target
$107
1%
downside
High target
$113
5%
upside

8 analyst ratings

positive
13%
neutral
63%
negative
25%
Morgan Stanley
Nigel Dally
5%upside
$113
Equal-Weight
Maintained
18 Aug 2025
Evercore ISI Group
Thomas Gallagher
2%downside
$106
Underperform
Maintained
15 Aug 2025
Wells Fargo
Elyse Greenspan
1%downside
$107
Equal-Weight
Maintained
11 Aug 2025
Keefe, Bruyette & Woods
Ryan Krueger
0%upside
$108
Market Perform
Maintained
11 Aug 2025
UBS
Brian Meredith
3%upside
$111
Neutral
Maintained
6 Aug 2025

Financial journalist opinion

Based on 18 articles about AFL published over the past 30 days

Positive
Seeking Alpha
4 days ago
Aflac: Best-In-Class Life Insurer Poised To Benefit From A Steepening Yield Curve
Buy Aflac for its high-interest rate sensitivity, superior financial strength, and best-in-class capital return strategy amid a steepening yield curve. Aflac's dominant Japan exposure, iconic brand, low debt/equity, and consistent dividend growth set it apart from peers like MetLife and Prudential. AFL offers a compelling 2.5x risk/reward to a $120 target (vs. $102 stop), supported by historical outperformance and a temporary slowdown in price momentum.
Aflac: Best-In-Class Life Insurer Poised To Benefit From A Steepening Yield Curve
Neutral
Seeking Alpha
4 days ago
Aflac: Q2 Earnings Indicate Slowing Growth (Rating Downgrade)
I am downgrading AFL to a hold due to slowing revenue and earnings growth and a premium valuation versus peers. AFL's Q2 results showed declining revenue and EPS, with investment losses and Japan segment weakness offsetting US segment growth. Despite a strong balance sheet and impressive dividend growth history, current valuation metrics limit near-term upside potential.
Aflac: Q2 Earnings Indicate Slowing Growth (Rating Downgrade)
Positive
Zacks Investment Research
5 days ago
All You Need to Know About Aflac (AFL) Rating Upgrade to Buy
Aflac (AFL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About Aflac (AFL) Rating Upgrade to Buy
Neutral
PRNewsWire
5 days ago
Aflac study reveals the impact of paid leave on employers and employees
Nearly 3 in 4 employees experience workplace stress or anxiety while covering for a peer 1 COLUMBUS, Ga. , Aug. 21, 2025 /PRNewswire/ -- Key findings from the second annual Time Away Study 1 released by Aflac, the leading provider of health supplemental insurance in the U.S.,2 reveal the significant physical, mental and professional challenges faced by employees who assume additional work when a co-worker is on leave.
Aflac study reveals the impact of paid leave on employers and employees
Neutral
Forbes
1 week ago
Ex-Dividend Reminder: Loews, AFLAC And Marketaxess Holdings
On 8/20/25, Loews, AFLAC, and Marketaxess Holdings will all trade ex-dividend for their respective upcoming dividends. Loews will pay its quarterly dividend of $0.0625 on 9/2/25, AFLAC will pay its quarterly dividend of $0.58 on 9/2/25, and Marketaxess Holdings will pay its quarterly dividend of $0.76 on 9/3/25.
Ex-Dividend Reminder: Loews, AFLAC And Marketaxess Holdings
Positive
Zacks Investment Research
1 week ago
Aflac Loads the Buyback Cannon as New Sales Signal Strength
AFL boosts its buyback plan to 130.9M shares as strong sales in Japan and higher U.S. margins fuel shareholder returns.
Aflac Loads the Buyback Cannon as New Sales Signal Strength
Neutral
PRNewsWire
1 week ago
Aflac Incorporated Announces Increase in Shares Authorized for Repurchase
COLUMBUS, Ga. , Aug. 12, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today announced that its Board of Directors has authorized the purchase of up to 100 million shares of its common stock.
Aflac Incorporated Announces Increase in Shares Authorized for Repurchase
Positive
Zacks Investment Research
2 weeks ago
Aflac Q2 Earnings Beat Estimates on Solid Cancer Product Sales
AFL's Q2 earnings benefit from robust Japan cancer insurance sales and strong persistency rates in the U.S. business, partly offset by rising costs.
Aflac Q2 Earnings Beat Estimates on Solid Cancer Product Sales
Neutral
Seeking Alpha
2 weeks ago
Aflac Incorporated (AFL) Q2 2025 Earnings Call Transcript
Aflac Incorporated (NYSE:AFL ) Q2 2025 Earnings Call August 6, 2025 8:00 AM ET Company Participants Daniel Paul Amos - Chairman & CEO David Young - Corporate Participant Koichiro Yoshizumi - Senior Managing Exec. Officer and Asst.
Aflac Incorporated (AFL) Q2 2025 Earnings Call Transcript
Neutral
The Motley Fool
2 weeks ago
Aflac (AFL) EPS Beats Sales Drop 19%
Aflac (AFL) EPS Beats Sales Drop 19%
Aflac (AFL) EPS Beats Sales Drop 19%
Charts implemented using Lightweight Charts™